Therapeutic hypothermia for acute stroke

Patrick D. Lyden, Derk Krieger, Midori Yenari, W. Dalton Dietrich

Research output: Contribution to journalReview article

73 Scopus citations

Abstract

Hypothermia is the most potent neuroprotective therapy available. Clinical use of hypothermia is limited by technology and homeostatic mechanisms that maintain core body temperature. Recent advances in intravascular cooling catheters and successful trials of hypothermia for cardiac arrest revivified interest in hypothermia for stroke, resulting in Phase 1 clinical trials and plans for further development. Given the recent spate of neuroprotective therapy failures, we sought to clarify whether clinical trials of therapeutic hypothermia should be mounted in stroke patients. We reviewed the preclinical and early clinical trials of hypothermia for a variety of indications, the putative mechanisms for neuroprotection with hypothermia, and offer several hypotheses that remain to be tested in clinical trials. Therapeutic hypothermia is promising, but further Phase 1 and Phase 2 development efforts are needed to ensure that cooling of stroke patients is safe, before definitive efficacy trials.

Original languageEnglish (US)
Pages (from-to)9-19
Number of pages11
JournalInternational Journal of Stroke
Volume1
Issue number1
DOIs
StatePublished - Feb 1 2006

ASJC Scopus subject areas

  • Neurology

Fingerprint Dive into the research topics of 'Therapeutic hypothermia for acute stroke'. Together they form a unique fingerprint.

  • Cite this